iOS app Android app

Sovaldi Hepatitis C

How Much Did Medicaid Programs Spend on Sovaldi in 2014?

Joshua Liao | Posted 09.24.2016 | Healthy Living
Joshua Liao

It is important to remember that Daraprim is not the first or only drug in recent years to cause concern among physicians, policymakers, patients and the public.

Gilead Sciences: A Profile in Congressionally Guaranteed Profiteering

David Belk | Posted 04.11.2015 | Business
David Belk

Industries have every right to make a profit. But should any industry be allowed unbridled profits by outlawing any possible check on their prices? A market is supposed to have two sides negotiating prices.

Drugs and Dollars

David Blumenthal | Posted 09.30.2014 | Politics
David Blumenthal

Tough as it is, having highly effective, but expensive, new treatments is a good problem to have. These drugs mean longer, better lives for humans the world over. We need to foster competitive markets and public policies that enable us to benefit.